What Happened?
, -based Chinook Therapeutics Appointed Andrew Oxtoby as chief commercial officer.
About the Company
Kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. In the U.S. alone, kidney diseases affect an estimated 37 million people and account for over $100 billion in annual costs.
About the Person
Andrew Oxtoby is chief commercial officer. at Chinook Therapeutics. Previously, Andrew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile